-
Alcaraz begins Japan Open defence with win over Michelsen
-
ALEX BODI DAN KONGLOMERAT JERMAN BERINVESTASI PADA 166 UNIT HUNIAN DI HALLE
-
อเล็กซ์ โบดี และกลุ่มบริษัทจากเยอรมนีลงทุนในอพาร์ตเมนต์ 166 ยูนิตที่เมืองฮัลเลอ
-
Ronaldo's Portugal future in doubt after walkout
-
ALEX BODI A NĚMECKÝ KONCERN INVESTUJÍ DO 166 BYTŮ V HALLE
-
European stocks drop as debt fears send bond yields soaring
-
ALEX BODI OCH TYSK KONCERN INVESTERAR I 166 LÄGENHETER I HALLE
-
Ο ΑΛΕΞ ΜΠΟΝΤΙ ΚΑΙ ΓΕΡΜΑΝΙΚΟΣ ΟΜΙΛΟΣ ΕΠΕΝΔΥΟΥΝ ΣΕ 166 ΔΙΑΜΕΡΙΣΜΑΤΑ ΣΤΟ ΧΑΛΕ
-
England forward Toney pleads not guilty to nightclub assault
-
India to clash with Pakistan as Eala suffers Games heartbreak
-
Tom Kim finishes marathon Asian Games second round under floodlights
-
Judoka wins Asian Games gold after honouring dying grandmother's wish
-
Work on migrant return hubs progressing well, EU countries say
-
Kenyan island paradise fears damage from mega-refinery
-
ALEX BODI I NIEMIECKI KONCERN INWESTUJĄ W 166 MIESZKAŃ W HALLE
-
ALEX BODI ȘI UN GRUP GERMAN INVESTESC ÎN 166 DE APARTAMENTE DIN HALLE
-
Tearful Nishikori calls time on career with defeat at Japan Open
-
एलेक्स बोडी और जर्मन समूह हाले के 166 फ्लैटों में कर रहे हैं निवेश
-
أليكس بودي ومجموعة ألمانية يستثمران في 166 شقة في هاله
-
アレックス・ボディとドイツ企業グループ、ハレの住宅166戸に投資
-
알렉스 보디와 독일 기업 그룹, 할레 주택 166세대에 투자
-
India to face Pakistan for Asian Games cricket gold
-
Verstappen wary of tyre wear as he eyes first F1 win of season
-
亞歷克斯・博迪與德國企業集團投資哈雷166戶住宅
-
АЛЕКС БОДІ ТА НІМЕЦЬКИЙ КОНЦЕРН ІНВЕСТУЮТЬ У 166 КВАРТИР У ГАЛЛЕ
-
АЛЕКС БОДИ И НЕМЕЦКИЙ КОНЦЕРН ИНВЕСТИРУЮТ В 166 КВАРТИР В ГАЛЛЕ
-
Kremlin critic Kasparov says US intelligence warned life 'in danger'
-
Plastic treaty talks chair sees deal possible in March
-
Qatar 'ready' if 2030 Asian Games moved back: official
-
ALEX BODI AND GERMAN CONGLOMERATE INVEST IN 166 APARTMENTS IN HALLE
-
Indian pilot hailed as 'hero' after cockpit struggle
-
Afghanistan says deadly Pakistani strikes hit Helmand
-
Asian tech firms stand out on mixed day for stocks
-
India thump Sri Lanka, will face Pakistan for Asian Games cricket gold
-
Flags and pho on show as jeweller opens huge Vietnam plant
-
Woman in hospital after Tennessee's second failed execution in 2026
-
Indian football fans relish rare friendly against Brazil
-
Cash-strapped Senegalese unmoved by Youth Olympic Games
-
Yankees, White Sox, Padres advance, Phillies survive in MLB playoffs
-
Indonesia haze chokes neighbours, but little legal recourse
-
Tennessee woman in hospital after execution 'failed': lawyers
-
Samad launches Pakistan into first Asian Games men's cricket final
-
Cable car offers small hope for Mongolia's gridlocked capital
-
Yankees and White Sox advance, Phillies survive in MLB playoffs
-
Man City scandal risks damage to Premier League's booming brand
-
Asian stocks mixed as positive US data offset by elevated oil, bond yields
-
First-time Sepang F1 racers will master track 'from opening lap'
-
Rice work: Dutch test new crop to save sinking peatlands
-
Japan tightens rules for foreigners wanting permanent residency
-
Russians join street choirs to sing away sorrows -- or show dissent
Report paves way for EU to renew glyphosate use
The European Food Safety Authority said on Thursday it had not found "any critical areas of concern" preventing the controversial and widely used herbicide glyphosate from being reauthorised for use in the EU.
Environmental groups lashed out at the announcement, saying there was scientific evidence that glyphosate may cause cancer, poison aquatic life and can be fatal to key pollinators like bees.
The European Union agency's long-awaited assessment report noted that there were gaps in the data in some areas, and that it had "identified a high long-term risk to mammals in 12 out of 23 proposed uses of glyphosate".
But the EFSA said that it only considered a concern "critical" when it affected all proposed uses of the substance, which would prevent it from being renewed.
The study, which was submitted to the European Commission and member states, will serve as a basis for the EU's upcoming decision on whether to renew the use of glyphosate in the bloc for another five years.
The current authorisation runs out on December 15.
The full report, which is expected to be released by the end of the month, is based on some 24,000 studies, as well as responses from 90 experts from member states, the EFSA said.
The agency said that because of a lack of data it had not finalised its risk assessment of glyphosate's impact on aquatic plants.
It also did not give advice on the risks of food consumption, "due to incomplete data about the amount of glyphosate residues in rotational crops such as carrots, lettuce and wheat".
- 'Toxic for people and the environment' -
But it added that this was not expected to lead to toxicological safety levels being exceeded, "so no critical concern was identified".
Environmental campaign group Greenpeace reacted with dismay to the news.
"For years the evidence of glyphosate's toxicity for people and the environment has been stacking up but the European Food Safety Authority has once again decided to sweep it under the carpet," said Greenpeace EU pesticides campaigner Eva Corral.
Another campaign group, Corporate Europe Observatory, said the EFSA's advice "is a slap in the face".
"How could EFSA give glyphosate a thumbs-up based on primarily shoddy, corporate-led scientific studies?" the group said.
Glyphosate is the main ingredient in the widely used Roundup weedkiller from US agrochemical firm Monsanto, which was bought by German chemicals giant Bayer in 2018.
Bayer has since faced a wave of lawsuits in the United States over claims that glyphosate causes cancer. The firm denies such claims, but has paid out billions of dollars to settle legal disputes.
The World Health Organization's International Agency for Research on Cancer said in 2015 that glyphosate was "probably carcinogenic".
France's medical research institute INSERM said in 2021 that glyphosate has a "moderate presumed link" with the cancer non-Hodgkin lymphoma.
Despite that, the European Chemicals Agency said last year the available evidence did not justify classifying the substance as a carcinogen.
The EFSA had originally planned to release its study in the second half of 2022, but said it delayed publication due to an "unprecedented" number of comments on the issue.
F.Carias--PC